Piascledine Side Effects

Common Piascledine Side Effects

The most commonly reported Piascledine side effects (click to view or check a box to report):

Tachycardia (1)
Syncope (1)
Sudden Death (1)
Renal Failure (1)
Thrombophlebitis (1)
Torticollis (1)
Neutropenia (1)
Oedema Peripheral (1)
Tremor (1)
Pulmonary Embolism (1)
Porphyrins Urine Increased (1)
Pallor (1)
Osteoarthritis (1)
Orthostatic Hypotension (1)
Palpitations (1)
Pancytopenia (1)
Porphyrins Stool Increased (1)
Porphyrin Metabolism Disorder (1)
Porphyria Non-acute (1)
Anaphylactic Shock (1)

➢ More

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Piascledine Side Effects Reported to FDA

The following Piascledine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Piascledine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
This is a report of a 78-year-old female patient (weight: NA) from FRANCE, suffering from the following symptoms/conditions: hypertension,bipolar disorder, who was treated with Piascledine (dosage: Avocado Oil Unsaponifiables And Soya Oil Unsaponifiables, start time: Jul 01, 2011), combined with:
  • Tegretol
  • Abilify (10 Mg Morning And 20 Mg Evening)
  • Levothyroxine Sodium (Levothyrox (levothyroxin Sodium) 75 Mg Morning)
  • Fenofibrate
  • Cozaar
and developed a serious reaction and side effect(s). The consumer presented with:
  • Delusion
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Piascledine treatment in female patients, resulting in delusion side effect.

Palpitations, Tachycardia, Chills, Infusion Related Reaction
This report suggests a potential Piascledine /01305801/ Palpitations, Tachycardia, Chills, Infusion Related Reaction side effect(s) that can have serious consequences. A female patient (weight: NA) from FRANCE was diagnosed with the following symptoms/conditions: NA and used Piascledine /01305801/ (dosage: 1 G, 1x/day:qd) starting Dec 20, 2011. Soon after starting Piascledine /01305801/ the patient began experiencing various side effects, including:
  • Palpitations
  • Tachycardia
  • Chills
  • Infusion Related Reaction
Drugs used concurrently:
  • Caltrate /00751519/ (600 Mg, 1x/day:qd)
  • Augmentin '125'
  • Vpriv
  • Birodogyl
The patient was hospitalized. Although Piascledine /01305801/ demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as palpitations, may still occur.

Torticollis, Arthralgia, Oedema Peripheral, Gastrointestinal Haemorrhage, Muscle Contracture
This Torticollis, Arthralgia, Oedema Peripheral, Gastrointestinal Haemorrhage, Muscle Contracture problem was reported by a health professional from DENMARK. A 72-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Nov 16, 2011 this consumer started treatment with Piascledine (avocado Oil, Soya Oil) (300 Milligram, Tablets) (avocado (dosage: NA). The following drugs were being taken at the same time:
  • Topalgic (tramadol Hydrochloride) (200 Milligram, Tablets) (tramadol H
  • Lexomil (bromazepam) (tablets) (bromazepam)
  • Escitalopram (1 Dosage Form (1 Dosage Forms, 1 In 1 D), Oral)
When commencing Piascledine (avocado Oil, Soya Oil) (300 Milligram, Tablets) (avocado, the patient experienced the following unwanted symptoms/side effects:
  • Torticollis
  • Arthralgia
  • Oedema Peripheral
  • Gastrointestinal Haemorrhage
  • Muscle Contracture
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as torticollis, may become evident only after a product is in use by the general population.

Asthenia, Pancytopenia, Weight Decreased, Anaphylactic Shock, Castleman's Disease
This is a report of a 45-year-old female patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: NA and was treated with Piascledine (dosage: NA) starting Aug 11, 2010. Concurrently used drugs:
  • Norvir
  • Sustiva
  • Prezista
  • Nevirapine
  • Isentress
  • Isentress
  • Viread
  • Reyataz
Soon after that, the consumer experienced the following side effects:
  • Asthenia
  • Pancytopenia
  • Weight Decreased
  • Anaphylactic Shock
  • Castleman's Disease
The patient was hospitalized. This opens a possibility that Piascledine treatment could cause the above reactions, including asthenia, and some female subjects may be more susceptible.

Thrombophlebitis, Chest Pain, Pulmonary Embolism
A female patient (weight: NA) from FRANCE with the following symptoms/conditions: NA started Piascledine treatment (dosage: NA) on NS. Soon after starting Piascledine treatment, the subject experienced various side effects, including:
  • Thrombophlebitis
  • Chest Pain
  • Pulmonary Embolism
Concurrently used drugs:
  • Fenofibrate
  • Pradaxa
  • Valsartan And Hydrochlorothiazide
  • Pradaxa (150 Mg)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Piascledine.

A male patient from UNITED KINGDOM (weight: NA) experienced symptoms, such as: NA and was treated with Piascledine(dosage: Unk). The treatment was initiated on Nov 15, 2010. After that a consumer reported the following side effect(s):
  • Tremor
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Piascledine efficacy:
  • Ondansertron Hydrochloride (Unk)
  • Bricanyl (Unk)
  • Ceris (Unk)
  • Bendamustine (300 Mg, Q4w)
  • Pravastatin Sodium (Unk)
  • Atrovent (Unk)
  • Diltiazem (Unk)
  • Rituximab (825 Mg, Q4w)
The patient was hospitalized.

In this report, Piascledine was administered for the following condition: NA.A female consumer from FRANCE (weight: NA) started Piascledine treatment (dosage: NA) on Jan 01, 2008.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Neutropenia
A possible interaction with other drugs could have contributed to this reaction:
  • Lapatinib (1250mg Per Day)
  • Allopurinol
  • Docetaxel
  • Levothyroxine Sodium
  • Imovane
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Piascledine treatment could be related to the listed above side effect(s).

Joint Injury, Osteoarthritis, Nausea
This is a report of the following Piascledine /00809501/ side effect(s):
  • Joint Injury
  • Osteoarthritis
  • Nausea
A 67-year-old female patient from FRANCE (weight: NA) presented with the following condition: NA and received a treatment with Piascledine /00809501/ (dosage: 1 Dosage, Daily (1/d)) starting: Mar 23, 2010.The following concurrently used drugs could have generated interactions:
  • Forteo (20 Ug, Daily (1/d))
The patient was hospitalized.This report suggests that a Piascledine /00809501/ treatment could be associated with the listed above side effect(s).

Iron Metabolism Disorder, Porphyria Non-acute, Porphyrin Metabolism Disorder, Porphyrins Stool Increased, Porphyrins Urine Increased
This Piascledine report was submitted by a male consumer from FRANCE (weight: NA). The patient was diagnosed with: NA and Piascledine was administered (dosage: NA) starting: Jun 29, 2006. The consumer developed a set of symptoms:
  • Iron Metabolism Disorder
  • Porphyria Non-acute
  • Porphyrin Metabolism Disorder
  • Porphyrins Stool Increased
  • Porphyrins Urine Increased
Other drugs used simultaneously:
  • Hysaar
  • Levothyroxine Sodium
  • Plavix
Those unexpected symptoms could be linked to a Piascledine treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Cardio-respiratory Arrest
This is a report of a possible correlation between Piascledine use and the following symptoms/side effect(s):
  • Cardio-respiratory Arrest
which could contribute to an assessment of Piascledine risk profile.A 61-year-old male consumer from FRANCE (weight: NA) was suffering from NA and was treated with Piascledine (dosage: Unk) starting Jun 03, 2006.Other concurrent medications:
  • Tanakan (120 Mg)
  • Risperdal
  • Risperdal
  • Risperdal
  • Rivotril
  • Risperdal Consta Lp (1 Vial Nos Every Two Weeks)
  • Noctamide
  • Stilnox (Unk)

Blood Creatinine Increased, Creatinine Renal Clearance Decreased, Discomfort, Faecal Incontinence, Malaise, Orthostatic Hypotension, Pallor, Renal Failure, Syncope
A 91-year-old female patient from FRANCE (weight: NA) presented with the following symptoms: NA and after a treatment with Piascledine (dosage: NA) experienced the following side effect(s):
  • Blood Creatinine Increased
  • Creatinine Renal Clearance Decreased
  • Discomfort
  • Faecal Incontinence
  • Malaise
  • Orthostatic Hypotension
  • Pallor
  • Renal Failure
  • Syncope
The treatment was started on NS. Piascledine was used in combination with the following drugs:
  • Orocal
  • Tanakan
  • Ditropan
  • Diffu K
  • Briazide (1 Df, Qd)
The patient was hospitalized.This report could alert potential Piascledine consumers.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Piascledine Side Effects

    Did You Have a Piascledine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor

    How Effective is Piascledine for You?

    Exceeded Expectations
    Somewhat Effective
    Not Effective